Clinical Trial Update: Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma

View source ↗

Summary

This clinical trial evaluated FLT PET and MRI imaging biomarkers to assess early treatment response in glioblastoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioblastoma | Status: COMPLETED